Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Hemasphere
|
December 29, 2021
High Prevalence of Constitutional Mismatch Repair Deficiency in a Pediatric T-cell Lymphoblastic Lymphoma Cohort
Emma Kroeze, Dilys D Weijers, Melanie M Hagleitner, et al.
Pediatric Blood & Cancer
|
August 28, 2023
<sup>18</sup> F-FDG-PET/CT imaging in diagnostic workup of pediatric precursor B-cell lymphoblastic lymphoma
Emma Kroeze, Laura Arias Padilla, Birgit Burkhardt, et al.
Frontiers in Pharmacology
|
September 9, 2020
Analysis of Drug Metabolizing Gene Panel in Osteosarcoma Patients Identifies Association Between Variants in <i>SULT1E1, CYP2B6</i> and <i>CYP4F8</i> and Methotrexate Levels and Toxicities
Evelien G E Hurkmans, Marije J Klumpers, Sita H Vermeulen, et al.
Plos One
|
January 1, 2015
Influence of genetic variants in TPMT and COMT associated with cisplatin induced hearing loss in patients with cancer: two new cohorts and a meta-analysis reveal significant heterogeneity between cohorts
Melanie M Hagleitner, Marieke J H Coenen, Ana Patino-Garcia, et al.
Hemasphere
|
July 1, 2024
NOTCH1 fusions in pediatric T-cell lymphoblastic lymphoma: A high-risk subgroup with CCL17 (TARC) levels as diagnostic biomarker
Emma Kroeze, Michelle M Kleisman, Lennart A Kester, et al.
Leukemia
|
December 9, 2025
Role of common host genome variants in Childhood Acute Lymphoblastic Leukemia
Theis Mikkelsen, Marianne Helenius, Mirella Ampatzidou, et al.
Blood
|
October 29, 2025
High-grade/large B-cell lymphoma-11q has a very good prognosis in children and young people without a predisposition
Leila Ronceray, Minke H W Huibers, Katrin Reutter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 2, 2015
A First Step toward Personalized Medicine in Osteosarcoma: Pharmacogenetics as Predictive Marker of Outcome after Chemotherapy-Based Treatment
Melanie M Hagleitner, Marieke J H Coenen, Hans Gelderblom, et al.
Cancers
|
August 26, 2022
Pediatric Precursor B-Cell Lymphoblastic Malignancies: From Extramedullary to Medullary Involvement
Emma Kroeze, Laura Arias Padilla, Max Bakker, et al.
The Lancet. Haematology
|
June 25, 2021
Severe toxicity free survival: physician-derived definitions of unacceptable long-term toxicities following acute lymphocytic leukaemia
Liv Andrés-Jensen, Andishe Attarbaschi, Edit Bardi, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Hemasphere
|
December 29, 2021
High Prevalence of Constitutional Mismatch Repair Deficiency in a Pediatric T-cell Lymphoblastic Lymphoma Cohort
Emma Kroeze, Dilys D Weijers, Melanie M Hagleitner, et al.
Pediatric Blood & Cancer
|
August 28, 2023
<sup>18</sup> F-FDG-PET/CT imaging in diagnostic workup of pediatric precursor B-cell lymphoblastic lymphoma
Emma Kroeze, Laura Arias Padilla, Birgit Burkhardt, et al.
Frontiers in Pharmacology
|
September 9, 2020
Analysis of Drug Metabolizing Gene Panel in Osteosarcoma Patients Identifies Association Between Variants in <i>SULT1E1, CYP2B6</i> and <i>CYP4F8</i> and Methotrexate Levels and Toxicities
Evelien G E Hurkmans, Marije J Klumpers, Sita H Vermeulen, et al.
Plos One
|
January 1, 2015
Influence of genetic variants in TPMT and COMT associated with cisplatin induced hearing loss in patients with cancer: two new cohorts and a meta-analysis reveal significant heterogeneity between cohorts
Melanie M Hagleitner, Marieke J H Coenen, Ana Patino-Garcia, et al.
Hemasphere
|
July 1, 2024
NOTCH1 fusions in pediatric T-cell lymphoblastic lymphoma: A high-risk subgroup with CCL17 (TARC) levels as diagnostic biomarker
Emma Kroeze, Michelle M Kleisman, Lennart A Kester, et al.
Leukemia
|
December 9, 2025
Role of common host genome variants in Childhood Acute Lymphoblastic Leukemia
Theis Mikkelsen, Marianne Helenius, Mirella Ampatzidou, et al.
Blood
|
October 29, 2025
High-grade/large B-cell lymphoma-11q has a very good prognosis in children and young people without a predisposition
Leila Ronceray, Minke H W Huibers, Katrin Reutter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 2, 2015
A First Step toward Personalized Medicine in Osteosarcoma: Pharmacogenetics as Predictive Marker of Outcome after Chemotherapy-Based Treatment
Melanie M Hagleitner, Marieke J H Coenen, Hans Gelderblom, et al.
Cancers
|
August 26, 2022
Pediatric Precursor B-Cell Lymphoblastic Malignancies: From Extramedullary to Medullary Involvement
Emma Kroeze, Laura Arias Padilla, Max Bakker, et al.
The Lancet. Haematology
|
June 25, 2021
Severe toxicity free survival: physician-derived definitions of unacceptable long-term toxicities following acute lymphocytic leukaemia
Liv Andrés-Jensen, Andishe Attarbaschi, Edit Bardi, et al.
Page
of 3